Profile of T cell immune responses in HIV-infected children from Uganda

Journal of Infectious Diseases

Volumn 196, Issue 11, 2007, Pages 1667-1670

  Ssewanyana, Isaac ^a   Elrefaei, Mohamed ^c   Dorsey, Grant ^d   Ruel, Theodore ^d   Jones, Norman G ^c   Gasasira, Anne ^b   Kamya, Moses ^b   Nakiwala, Justine ^b   Achan, Jane ^b   Charlebois, Edwin ^d   Havlir, Diane ^d   Cao, Huyen ^c  

^a JOINT CLINICAL RESEARCH CENTRE   (Uganda)

^b MAKERERE UNIVERSITY   (Uganda)

^c CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; GAG PROTEIN; GAMMA INTERFERON; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UGANDA; FEMALE; HELPER CELL; IMMUNOLOGY; INFANT; MALE; PRESCHOOL CHILD; T LYMPHOCYTE;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INTERFERON TYPE II; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2; MALE; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER; UGANDA;

EID: 38449094103     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/522013     Document Type: Article

References (15)

1. + T cell depletion, and coinfection. J Infect Dis 2005; 191:694-701.
2. Kaleebu P, French N, Mahe C, et al. Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 2002; 185:1244-50.
3. Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997; 278:1447-50.
4. McMichael AJ, Rowland-Jones SL. Cellular immune responses to HIV. Nature 2001; 410:980-7.
5. Dorsey G, Staedke S, Clark TD, et al. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA 2007; 297:2210-9.
6. Paul ME, Mao C, Charurat M, et al. Predictors of immunologic longterm nonprogression in HIV-infected children: implications for initiating therapy. J Allergy Clin Immunol 2005; 115:848-55.
7. + T-cell immunodeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2006; 42:269-76.
8. Grakoui A, Shoukry NH, Woollard DJ, et al. HCV persistence and immune evasion in the absence of memory T cell help. Science 2003; 302:659-62.
9. Jones N, Eggena M, Baker C, et al. Presence of distinct subsets of cytolytic CD8+ T cells in chronic HIV infection. AIDS Res Hum Retroviruses 2006; 22:1007-13.
10. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 396:690-5.
11. Plaeger-Marshall S, Isacescu V, O'Rourke S, Bertolli J, Bryson YJ, Stiehm ER. T cell activation in pediatric AIDS pathogenesis: three-color immunophenotyping. Clin Immunol Immunopathol 1994; 71:19-26.
12. Melvin AJ, Rodrigo AG, Mohan KM, et al. HIV-1 dynamics in children. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20:468-73.
13. Nahmias AJ, Clark WS, Kourtis AP, et al. Thymic dysfunction and time of infection predict mortality in human immunodeficiency virus-infected infants. CDC Perinatal AIDS Collaborative Transmission Study Group. J Infect Dis 1998; 178:680-5.
14. Kourtis AP, Ibegbu C, Nahmias AJ, et al. Early progression of disease in HIV-infected infants with thymus dysfunction. N Engl J Med 1996; 335:1431-6.
15. Sandberg JK, Fast NM, Jordan KA, et al. HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment. J Immunol 2003; 170:4403-10.